Pink Sheet Executive Editor Derrick Gingery, Editor-in-Chief Nielsen Hobbs, and special guest Michael McCaughan of Prevision Policy look at new Health and Human Services Secretary Robert F. Kennedy Jr.’s first assignment, a presidential commission on reducing chronic disease (:29), as well as former US Food and Drug Administration Commissioner Scott Gottlieb’s suggestion that industry extend the existing user fee program rather than negotiate a new agreement in the current political environment (13:30). They also discuss the impact of President Trump’s executive order mandating a reduction in force across the federal government on the US Food and Drug Administration and communications questions affecting the agency’s advisory committee schedule (25:16).
More On These Topics From The Pink Sheet
- Commission Led By HHS Secretary Kennedy Will Probe ‘Threats’ To Children, Including Medicines
- Bracing For RFK At HHS: Vaccine Safety Commission Likely First Step
- User Fees: Industry Should Push For Extension Of Current Agreement In Reconciliation Bill, Gottlieb Says
- Could PDUFA VIII Align With Trump’s Efficiency Emphasis?
- US FDA Advisory Committee Freeze Raises Concerns Of Delayed, More Controversial Approvals
- ‘This Is Not Good For Business’: Trump’s Workforce Shakeups Could Harm Industry
This and other podcasts are available on the Pink Sheet podcast page, as well as the Citeline channel on Apple Podcasts, SoundCloud, TuneIn and Spotify Podcasts, and via smart speakers if one of these platforms has been set up as your default podcast provider.
